Health
BIOCAD will produce the COVID-19 vaccine developed by Gamalei Institute – EurekAlert
On September 23, 2020, the biotechnology company BIOCAD signed an agreement on the industrial production of the COVID-19 vaccine with the Research Center for Epidemiology and Microbiology of the Ministry of Health of Russia named after V. Gamaleya. BIOCAD bec…
Clinical trials of the vaccine are currently underway. The «Sputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated introduction of a particle of coronavirus RNA, it is covered with a new adenovirus. This is done in order to exclude the presence of neutralizing antibodies against the vaccine in humans and thus enhance the reliability of repeated injection. The article on the «Sputnik V» vaccine was published b…
-
General18 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News17 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General23 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says
-
Noosa News18 hours agoThe Best Things to Do in Brisbane This New Year’s Eve